A room of errors simulation to improve pharmacy operators' knowledge of cytotoxic drug production.
chemotherapy
errors
knowledge assessment
pharmaceutical training
simulation
Journal
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
ISSN: 1477-092X
Titre abrégé: J Oncol Pharm Pract
Pays: England
ID NLM: 9511372
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
medline:
30
11
2023
pubmed:
8
2
2023
entrez:
7
2
2023
Statut:
ppublish
Résumé
We used an educational healthcare simulation tool called room of errors (ROE) to raise pharmacy operators' awareness of potential errors in a chemotherapy production process and assessed its impact on their knowledge and satisfaction. Twenty-five errors (compiled from internal procedures, literature and our hospital's reported incidents) were categorised as static ( The 14 participants detected 70.4% ± 11.4% of errors. Least-detected errors were "using non-disinfected vials" (42.9%) and "touching syringe plunger" (0%). Critical errors (expired leftovers or glucose instead of sodium chloride) were detected at 57.1%. Knowledge improved from 60.3% to 94.1% (p < 0.001) and certainty from 75.3% to 98.8% (p < 0.001). Participants appreciated this non-judgmental, informative, and original training (satisfaction 95.7%). Some pointed out difficulties settling into the game quickly and visualising static and dynamic errors simultaneously. This ROE simulation improved operators' knowledge and certainty. Longer-term testing should be done to measure knowledge retention over time.
Identifiants
pubmed: 36748798
doi: 10.1177/10781552231152145
pmc: PMC10687806
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1868-1877Déclaration de conflit d'intérêts
Author ContributionsAG and LBu designed the study. LBu collected the data and performed the analysis. AG and LBu interpreted the results. All authors reviewed and approved the final version of the manuscript. Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Patient Educ Couns. 2003 Sep;51(1):29-37
pubmed: 12915277
Eur J Hosp Pharm. 2023 Mar;30(2):70-76
pubmed: 34949651
BMJ Qual Saf. 2016 Mar;25(3):153-8
pubmed: 26621915
J Dent Educ. 2022 May;86(5):615-621
pubmed: 34961938
Consult Pharm. 2004 Nov;19(11):1029-37
pubmed: 16553486
Res Social Adm Pharm. 2016 Sep-Oct;12(5):772-83
pubmed: 26604005
J Oncol Pharm Pract. 2020 Jun;26(4):853-860
pubmed: 31566110
Nurse Educ Pract. 2021 May;53:103056
pubmed: 33930750
J Oncol Pharm Pract. 2019 Jul;25(5):1187-1194
pubmed: 30626271
Pharm World Sci. 2001 Jun;23(3):102-6
pubmed: 11468873
J Eval Clin Pract. 2016 Dec;22(6):907-916
pubmed: 27184006
Med Teach. 2005 Jan;27(1):10-28
pubmed: 16147767
J Oncol Pharm Pract. 2019 Mar;25(2):454-459
pubmed: 29237326